Eva Prescott

Eva Prescott

Clinical Professor

Member of:

  • Internal medicine: Cardiology


Publication year:
All
21 - 25 out of 25Page size: 10
Sort by: 1st author
  1. Published

    Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study

    Prescott, Eva, Angerås, O., Erlinge, D., Grove, E. L., Hedman, M., Jensen, L. O., Pernow, J., Saraste, A., Åkerblom, A., Svedlund, S., Rudvik, A., Knöchel, J., Lindstedt, E. L., Garkaviy, P., Gan, L. M. & Gabrielsen, A., 2022, In: International Journal of Cardiology. 365, p. 34-40 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Socioeconomic disparity in cardiovascular disease: Possible biological pathways based on a proteomic approach

    Shafi, B. H., Bøttcher, M., Ejupi, A., Jensen, G., Osler, Merete, Lange, Theis & Prescott, Eva, 2022, In: Atherosclerosis. 352, p. 62-68 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Age- and sex-based normal values of layer-specific longitudinal and circumferential strain by speckle tracking echocardiography: the Copenhagen City Heart Study

    Skaarup, K. G., Lassen, M. C. H., Johansen, N. D., Olsen, F. J., Lind, J. N., Jørgensen, P. G., Jensen, G., Schnohr, P., Prescott, Eva, Søgaard, P., Møgelvang, R. & Biering-Sørensen, Tor, 2022, In: European Heart Journal Cardiovascular Imaging. 23, 5, p. 629–640

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Effect of empagliflozin on coronary microvascular function in patients with type 2 diabetes mellitus-A randomized, placebo-controlled cross-over study

    Suhrs, H. E., Nilsson, M., Bove, K. B., Zander, M. & Prescott, Eva, 11 Feb 2022, In: PLoS ONE. 17, 2, 14 p., 0263481.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    2021 ESC/EACTS Guidelines for the management of valvular heart disease

    Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., Delgado, V., Freemantle, N., Gilard, M., Haugaa, K. H., Jeppsson, A., Jüni, P., Pierard, L., Prendergast, B. D., Sadaba, J. R., Tribouilloy, C. & 31 others, Wojakowski, W., Neumann, F. J., Myers, P., Abdelhamid, M., Achenbach, S., Asteggiano, R., Barili, F., Borger, M. A., Carrel, T., Collet, J. P., Foldager, D., Habib, G., Hassager, Christian, Irs, A., Iung, B., Jahangiri, M., Katus, H. A., Koskinas, K. C., Massberg, S., Mueller, C. E., Nielsen, J. C., Pibarot, P., Rakisheva, A., Roffi, M., Rubboli, A., Shlyakhto, E., Siepe, M., Sitges, M., Søndergaard, Lars, Prescott, Eva & ESC/EACTS Scientific Document Group, E. S. D. G., 2022, In: European Heart Journal. 43, 7, p. 561-632 72 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 Next

ID: 915491